Question 1

What is the ESG rating for AMRX?

Accepted Answer

Amneal Pharmaceuticals, Inc. has the following ESG ratings: ESG Enterprise Score: 35.9 (E:N/A S:N/A G:N/A).

Question 2

What are the main strengths of investing in AMRX?

Accepted Answer

The main strengths of investing in Amneal Pharmaceuticals, Inc. include: Strong corporate governance, Positive social impact, Strong commitment to environmental sustainability..

Question 3

What are the potential drawbacks of investing in AMRX?

Accepted Answer

Potential drawbacks of investing in Amneal Pharmaceuticals, Inc. include: High debt levels, Limited diversity and inclusion initiatives..

Question 4

What are the key financial metrics for AMRX?

Accepted Answer

Key financial metrics for Amneal Pharmaceuticals, Inc. include: Market Cap: $0.68 billion, Current Price: $56.36.

Amneal Pharmaceuticals, Inc.

Detailed View

AMRX

ESG Ratings